Arkolith/Insider Trading/PIRS/Form 4

Olwill Shane

Chief Development OfficerPIERIS PHARMACEUTICALS, INC. (PIRS) · full profile →Form 4 · filed Sep 1, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$196K
Net Open-Market Flow
-$196K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 30, 2021Option exercise(M)38K$1.52$58K43K
Aug 30, 2021Sell(S)29K$5.15$150K5K
Aug 30, 2021Sell(S)9K$5.00$46K34K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 30, 2021Option exercise(M)38K—$062K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-21-005712) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML